Blood Res.  2021 Mar;56(1):53-56. 10.5045/br.2021.2020299.

Utility of platelet cross-matching in a case of neonatal alloimmune thrombocytopenia associated with a de novo MECOM variant

• Datta SS
• Basu S
• Ghara N
• Kole P
• Khemka P

• KMID: 2514067
• DOI: http://doi.org/10.5045/br.2021.2020299

Abstract

No abstract available

Figure

• 

  Fig. 1 Day-wise changes observed in platelet counts after transfusion of cross-matched platelets and IVIG.

Reference

1. Kjeldsen-Kragh J, Killie MK, Tomter G, et al. 2007; A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thro-mbocytopenia. Blood. 110:833–9. DOI: 10.1182/blood-2006-08-040121. PMID: 17429009.

2. Mandelbaum M, Koren D, Eichelberger B, Auerbach L, Panzer S. 2005; Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Vox Sang. 89:39–43. DOI: 10.1111/j.1423-0410.2005.00662.x. PMID: 15938738.

3. Curtis BR, McFarland JG. 2014; Human platelet antigens - 2013. Vox Sang. 106:93–102. DOI: 10.1111/vox.12085. PMID: 24102564.

4. Peterson JA, McFarland JG, Curtis BR, Aster RH. 2013; Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 161:3–14. DOI: 10.1111/bjh.12235. PMID: 23384054. PMCID: PMC3895911.

5. Venkatesh HA, Paul A, Kantharaj A, Chandrashekar S. 2019; A case report of neonatal alloimmune thrombocytopenia: the utility of platelet crossmatch studies in the diagnosis and management. Glob J Transfus Med. 4:234–6. DOI: 10.4103/GJTM.GJTM_50_19.

6. Niihori T, Ouchi-Uchiyama M, Sasahara Y, et al. 2015; Mutations in MECOM, encoding oncoprotein EVI1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia. Am J Hum Genet. 97:848–54. DOI: 10.1016/j.ajhg.2015.10.010. PMID: 26581901. PMCID: PMC4678429.

7. Germeshausen M, Ancliff P, Estrada J, et al. 2018; MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Blood Adv. 2:586–96. DOI: 10.1182/bloodadvances.2018016501. PMID: 29540340. PMCID: PMC5873238.

8. Juskewitch JE, Norgan AP, De Goey SR, et al. 2017; How do I … manage the platelet transfusion-refractory patient? Transfusion. 57:2828–35. DOI: 10.1111/trf.14316. PMID: 28960321.

9. Nogues N, Garcia A, Julia MR, et al. 2006; Anti-HPA15 (gov) antibodies detected in two cases of neonatal alloimmune trombocytopenia and in one case of immune refractoriness to platelet transfusion. Vox Sang. 91(Suppl 2):16–17. DOI: 10.1111/j.1423-0410.2006.00801.x.

10. Gibson BE, Todd A, Roberts I, et al. 2004; Transfusion guidelines for neonates and older children. Br J Haematol. 124:433–53. DOI: 10.1111/j.1365-2141.2004.04815.x. PMID: 14984493.